Rachel E. Hewitt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rachel E. Hewitt has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
Jonathan J. Powell
University of Cambridge
10 shared publicationsJack Robertson
Department of Veterinary Medicine, University of Cambridge, Cambridge, UK
7 shared publications- David Anthony Price
Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK
6 shared publications Laetitia C. Pele
Biomineral Research Group, MRC Elsie Widdowson Laboratory, Fulbourn Road, Cambridge CB1 9NL, UK
6 shared publications- Jonathan J. Powell
Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, UK
5 shared publications - Carolin T. Turner
Institute of Infection, Immunity and Transplantation, University College London, United Kingdom
4 shared publications
Latest Publications
- 19 November 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
Interaction between membrane sphingolipids, PIEZO1 agonists and Ca 2+ in phosphatidylserine exposure in sickle red blood cells
Phosphatidylserine (PS) exposure by red blood cells (RBCs) promotes endothelial adhesion and coagulation in sickle cell disease (SCD), but how membrane lipid remodelling influences Ca 2+ -associated PS exposure remains unclear. We hypothesise that variable coupling between Ca 2+ entry, notably via the mechanosensitive cation channel PIEZO1, and PS scrambling is important in pathogenesis. Simultaneous Fluo-4/lactadherin-Alexa Fluor 647 flow cytometry was used to measure intracellular Ca 2+ and PS exposure in RBCs from patients homozygous for SCD (HbSS genotype) following exposure to C6-ceramide or sphingomyelinase (SMase). The effect of ceramide was also investigated on responses to the PIEZO1 agonists Yoda1 and Yaddle1. Ceramide increased PS exposure in the presence of extracellular Ca 2+ but not when it was absent. Following 10 min exposure, ceramide increased the Fluo-4⁺/PS⁺ population and median Fluo-4 fluorescence intensity (MFI) in PS + cells, whereas after 5 h, PS exposure remained elevated at 100 µM without a significant difference in MFI between PS + and PS - cells. SMase also increased PS exposure and produced a different Fluo-4/PS distribution, while responses were minimal in Ca 2+ -free conditions. Ceramide pre-treatment markedly enhanced Yoda1-evoked Ca 2+ increases and PS exposure, particularly at submaximal concentrations, and increased Yaddle1-evoked Fluo-4 fluorescence and the Fluo-4⁺/PS⁺ population at 8 and 16 µM. Benzbromarone and Dooku1 attenuated agonist-evoked responses. These findings show that sphingolipid remodelling alters the pattern of intracellular Ca 2+ and PS responses in HbSS RBCs.
- 19 November 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
Interaction between membrane sphingolipids, PIEZO1 agonists and Ca 2+ in phosphatidylserine exposure in sickle red blood cells
Phosphatidylserine (PS) exposure by red blood cells (RBCs) promotes endothelial adhesion and coagulation in sickle cell disease (SCD), but how membrane lipid remodelling influences Ca 2+ -associated PS exposure remains unclear. We hypothesise that variable coupling between Ca 2+ entry, notably via the mechanosensitive cation channel PIEZO1, and PS scrambling is important in pathogenesis. Simultaneous Fluo-4/lactadherin-Alexa Fluor 647 flow cytometry was used to measure intracellular Ca 2+ and PS exposure in RBCs from patients homozygous for SCD (HbSS genotype) following exposure to C6-ceramide or sphingomyelinase (SMase). The effect of ceramide was also investigated on responses to the PIEZO1 agonists Yoda1 and Yaddle1. Ceramide increased PS exposure in the presence of extracellular Ca 2+ but not when it was absent. Following 10 min exposure, ceramide increased the Fluo-4⁺/PS⁺ population and median Fluo-4 fluorescence intensity (MFI) in PS + cells, whereas after 5 h, PS exposure remained elevated at 100 µM without a significant difference in MFI between PS + and PS - cells. SMase also increased PS exposure and produced a different Fluo-4/PS distribution, while responses were minimal in Ca 2+ -free conditions. Ceramide pre-treatment markedly enhanced Yoda1-evoked Ca 2+ increases and PS exposure, particularly at submaximal concentrations, and increased Yaddle1-evoked Fluo-4 fluorescence and the Fluo-4⁺/PS⁺ population at 8 and 16 µM. Benzbromarone and Dooku1 attenuated agonist-evoked responses. These findings show that sphingolipid remodelling alters the pattern of intracellular Ca 2+ and PS responses in HbSS RBCs.
- Open Access
- 7 November 2025
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 222, 15-19
Diagnostic challenges of polyclonal B-cell lymphocytosis in an English Bulldog (PBLEB) and outcome following splenectomy
- 7 November 2025
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 222, 15-19
Open AccessDiagnostic challenges of polyclonal B-cell lymphocytosis in an English Bulldog (PBLEB) and outcome following splenectomy
- Open Access
- 7 August 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (29) , e01809
Multiscale Profiling of Nanoscale Metal‐Organic Framework Biocompatibility and Immune Interactions
The clinical translation of metal‐organic frameworks (MOFs) – a promising class of porous materials for nanomedicine – is hindered by a poor understanding of their complex interactions with the immune system and in vivo immunotoxicity. To address this gap, a hierarchical “Safety‐by‐Design” pipeline is established and validated, integrating machine learning (ML) with ex vivo human blood studies and targeted in vivo models. This multi‐stage workflow enables the systematic profiling of MOF immunotoxicity, de‐risking their development. The power of this approach is demonstrated using four clinically relevant MOFs – NU‐901, PCN‐222, UiO‐66, and ZIF‐8 – revealing distinct, framework‐dependent immune fingerprints. The initial in silico screening correctly flagged NU‐901 and ZIF‐8 as potential hazards to human health. These predictions are subsequently validated ex vivo, where NU‐901 is confirmed to be selectively cytotoxic to CD14 + monocytes, and ZIF‐8 is identified as a specific pro‐inflammatory agent via IL‐6 induction. In contrast, candidates predicted to be safe – UiO‐66 and PCN‐222 – demonstrated high biocompatibility ex vivo and advanced to in vivo studies, where they caused only minimal and transient immune activation. This study provides a validated, resource‐efficient roadmap for preclinical immunotoxicity assessment, establishing a rational paradigm to accelerate the safe clinical translation of MOFs and other advanced nanomedicines.
- 7 August 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 14 (29) , e01809
Open AccessMultiscale Profiling of Nanoscale Metal‐Organic Framework Biocompatibility and Immune Interactions
The clinical translation of metal‐organic frameworks (MOFs) – a promising class of porous materials for nanomedicine – is hindered by a poor understanding of their complex interactions with the immune system and in vivo immunotoxicity. To address this gap, a hierarchical “Safety‐by‐Design” pipeline is established and validated, integrating machine learning (ML) with ex vivo human blood studies and targeted in vivo models. This multi‐stage workflow enables the systematic profiling of MOF immunotoxicity, de‐risking their development. The power of this approach is demonstrated using four clinically relevant MOFs – NU‐901, PCN‐222, UiO‐66, and ZIF‐8 – revealing distinct, framework‐dependent immune fingerprints. The initial in silico screening correctly flagged NU‐901 and ZIF‐8 as potential hazards to human health. These predictions are subsequently validated ex vivo, where NU‐901 is confirmed to be selectively cytotoxic to CD14 + monocytes, and ZIF‐8 is identified as a specific pro‐inflammatory agent via IL‐6 induction. In contrast, candidates predicted to be safe – UiO‐66 and PCN‐222 – demonstrated high biocompatibility ex vivo and advanced to in vivo studies, where they caused only minimal and transient immune activation. This study provides a validated, resource‐efficient roadmap for preclinical immunotoxicity assessment, establishing a rational paradigm to accelerate the safe clinical translation of MOFs and other advanced nanomedicines.
- Open Access
- 4 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Immunocompetent cell targeting by food-additive titanium dioxide
Food-grade titanium dioxide (fgTiO2) is a bio-persistent particle under intense regulatory scrutiny. Yet paradoxically, the only known cell reservoirs for fgTiO2 are graveyard intestinal pigment cells which are metabolically and immunologically quiescent. Here we identify immunocompetent cell targets of fgTiO2 in humans, most notably in the subepithelial dome region of intestinal Peyer’s patches. Using multimodal microscopies with single-particle detection and per-cell / vesicle image analysis we achieve correlative dosimetry, quantitatively recapitulating human cellular exposures in the ileum of mice fed a fgTiO2-containing diet. Epithelial microfold cells selectively funnel fgTiO2 into LysoMac and LysoDC cells with ensuing accumulation. Notwithstanding, proximity extension analyses for 92 protein targets reveal no measureable perturbation of cell signalling pathways. When chased with oral ΔaroA-Salmonella, pro-inflammatory signalling is confirmed, but no augmentation by fgTiO2 is revealed despite marked same-cell loading. Interestingly, Salmonella causes the fgTiO2-recipient cells to migrate within the patch and, sporadically, to be identified in the lamina propria, thereby fully recreating the intestinal tissue distribution of fgTiO2 in humans. Immunocompetent cells that accumulate fgTiO2 in vivo are now identified and we demonstrate a mouse model that finally enables human-relevant risk assessments of ingested, bio-persistent (nano)particles.
- 4 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-19
Open AccessImmunocompetent cell targeting by food-additive titanium dioxide
Food-grade titanium dioxide (fgTiO2) is a bio-persistent particle under intense regulatory scrutiny. Yet paradoxically, the only known cell reservoirs for fgTiO2 are graveyard intestinal pigment cells which are metabolically and immunologically quiescent. Here we identify immunocompetent cell targets of fgTiO2 in humans, most notably in the subepithelial dome region of intestinal Peyer’s patches. Using multimodal microscopies with single-particle detection and per-cell / vesicle image analysis we achieve correlative dosimetry, quantitatively recapitulating human cellular exposures in the ileum of mice fed a fgTiO2-containing diet. Epithelial microfold cells selectively funnel fgTiO2 into LysoMac and LysoDC cells with ensuing accumulation. Notwithstanding, proximity extension analyses for 92 protein targets reveal no measureable perturbation of cell signalling pathways. When chased with oral ΔaroA-Salmonella, pro-inflammatory signalling is confirmed, but no augmentation by fgTiO2 is revealed despite marked same-cell loading. Interestingly, Salmonella causes the fgTiO2-recipient cells to migrate within the patch and, sporadically, to be identified in the lamina propria, thereby fully recreating the intestinal tissue distribution of fgTiO2 in humans. Immunocompetent cells that accumulate fgTiO2 in vivo are now identified and we demonstrate a mouse model that finally enables human-relevant risk assessments of ingested, bio-persistent (nano)particles.
- Open Access
- 28 February 2024
- Published by Center for Open Science in OSF Preprints
Towards meaningful interdisciplinary and cross-sectoral digital health collaborations: Challenges and action-oriented solutions
The development, evaluation, and implementation of digital health interventions requires contributions from scientists, healthcare professionals, and developers. Albeit exciting, interdisciplinary and cross-sectoral collaboration is challenging and so often slow and its impact limited. By outlining challenges and potential action-oriented solutions we aim to stimulate meaningful interdisciplinary and cross-sectoral collaborations.
- 28 February 2024
- Published by Center for Open Science in OSF Preprints
Open AccessTowards meaningful interdisciplinary and cross-sectoral digital health collaborations: Challenges and action-oriented solutions
The development, evaluation, and implementation of digital health interventions requires contributions from scientists, healthcare professionals, and developers. Albeit exciting, interdisciplinary and cross-sectoral collaboration is challenging and so often slow and its impact limited. By outlining challenges and potential action-oriented solutions we aim to stimulate meaningful interdisciplinary and cross-sectoral collaborations.
- 20 April 2023
- Published by Springer Nature
- Vol. 2635, 135-148
Label-Free Identification of Persistent Particles in Association with Primary Immune Cells by Imaging Flow Cytometry
The frequency of human exposure to persistent particles via consumer products, air pollution, and work environments is a modern-day hazard and an active area of research. Particle density and crystallinity, which often dictate their persistence in biological systems, are associated with strong light absorption and reflectance. These attributes allow several persistent particle types to be identified without the use of additional labels using laser light-based techniques such as microscopy, flow cytometry, and imaging flow cytometry. This form of identification allows the direct analysis of environmental persistent particles in association with biological samples after in vivo studies and real-life exposures. Microscopy and imaging flow cytometry have progressed with computing capabilities and fully quantitative imaging techniques can now plausibly detail the interactions and effects of micron and nano-sized particles with primary cells and tissues. This chapter summarises studies which have utilized the strong light absorption and reflectance characteristics of particles for their detection in biological specimens. This is followed by the description of methods for the analysis of whole blood samples and the use of imaging flow cytometry to identify particles in association with primary peripheral blood phagocytic cells, using brightfield and darkfield parameters. Key words Nanoparticle Microparticle Whole blood Neutrophils Imaging flow cytometry Label-free imaging Persistent particles
- 20 April 2023
- Published by Springer Nature
- Vol. 2635, 135-148
Label-Free Identification of Persistent Particles in Association with Primary Immune Cells by Imaging Flow Cytometry
The frequency of human exposure to persistent particles via consumer products, air pollution, and work environments is a modern-day hazard and an active area of research. Particle density and crystallinity, which often dictate their persistence in biological systems, are associated with strong light absorption and reflectance. These attributes allow several persistent particle types to be identified without the use of additional labels using laser light-based techniques such as microscopy, flow cytometry, and imaging flow cytometry. This form of identification allows the direct analysis of environmental persistent particles in association with biological samples after in vivo studies and real-life exposures. Microscopy and imaging flow cytometry have progressed with computing capabilities and fully quantitative imaging techniques can now plausibly detail the interactions and effects of micron and nano-sized particles with primary cells and tissues. This chapter summarises studies which have utilized the strong light absorption and reflectance characteristics of particles for their detection in biological specimens. This is followed by the description of methods for the analysis of whole blood samples and the use of imaging flow cytometry to identify particles in association with primary peripheral blood phagocytic cells, using brightfield and darkfield parameters. Key words Nanoparticle Microparticle Whole blood Neutrophils Imaging flow cytometry Label-free imaging Persistent particles
- Open Access
- 11 April 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14
Editorial: Modulation of the immune system by nanoparticles
Editorial: Modulation of the immune system by nanoparticles
- 11 April 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14
Open AccessEditorial: Modulation of the immune system by nanoparticles
Editorial: Modulation of the immune system by nanoparticles
- Open Access
- 6 August 2021
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 143 (34) , 13557-13572
Formulation of Metal–Organic Framework-Based Drug Carriers by Controlled Coordination of Methoxy PEG Phosphate: Boosting Colloidal Stability and Redispersibility
Metal–organic framework nanoparticles (nanoMOFs) have been widely studied in biomedical applications. Although substantial efforts have been devoted to the development of biocompatible approaches, the requirement of tedious synthetic steps, toxic reagents, and limitations on the shelf life of nanoparticles in solution are still significant barriers to their translation to clinical use. In this work, we propose a new postsynthetic modification of nanoMOFs with phosphate-functionalized methoxy polyethylene glycol (mPEG–PO3) groups which, when combined with lyophilization, leads to the formation of redispersible solid materials. This approach can serve as a facile and general formulation method for the storage of bare or drug-loaded nanoMOFs. The obtained PEGylated nanoMOFs show stable hydrodynamic diameters, improved colloidal stability, and delayed drug-release kinetics compared to their parent nanoMOFs. Ex situ characterization and computational studies reveal that PEGylation of PCN-222 proceeds in a two-step fashion. Most importantly, the lyophilized, PEGylated nanoMOFs can be completely redispersed in water, avoiding common aggregation issues that have limited the use of MOFs in the biomedical field to the wet form—a critical limitation for their translation to clinical use as these materials can now be stored as dried samples. The in vitro performance of the addition of mPEG–PO3 was confirmed by the improved intracellular stability and delayed drug-release capability, including lower cytotoxicity compared with that of the bare nanoMOFs. Furthermore, z-stack confocal microscopy images reveal the colocalization of bare and PEGylated nanoMOFs. This research highlights a facile PEGylation method with mPEG–PO3, providing new insights into the design of promising nanocarriers for drug delivery.
- 6 August 2021
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 143 (34) , 13557-13572
Open AccessFormulation of Metal–Organic Framework-Based Drug Carriers by Controlled Coordination of Methoxy PEG Phosphate: Boosting Colloidal Stability and Redispersibility
Metal–organic framework nanoparticles (nanoMOFs) have been widely studied in biomedical applications. Although substantial efforts have been devoted to the development of biocompatible approaches, the requirement of tedious synthetic steps, toxic reagents, and limitations on the shelf life of nanoparticles in solution are still significant barriers to their translation to clinical use. In this work, we propose a new postsynthetic modification of nanoMOFs with phosphate-functionalized methoxy polyethylene glycol (mPEG–PO3) groups which, when combined with lyophilization, leads to the formation of redispersible solid materials. This approach can serve as a facile and general formulation method for the storage of bare or drug-loaded nanoMOFs. The obtained PEGylated nanoMOFs show stable hydrodynamic diameters, improved colloidal stability, and delayed drug-release kinetics compared to their parent nanoMOFs. Ex situ characterization and computational studies reveal that PEGylation of PCN-222 proceeds in a two-step fashion. Most importantly, the lyophilized, PEGylated nanoMOFs can be completely redispersed in water, avoiding common aggregation issues that have limited the use of MOFs in the biomedical field to the wet form—a critical limitation for their translation to clinical use as these materials can now be stored as dried samples. The in vitro performance of the addition of mPEG–PO3 was confirmed by the improved intracellular stability and delayed drug-release capability, including lower cytotoxicity compared with that of the bare nanoMOFs. Furthermore, z-stack confocal microscopy images reveal the colocalization of bare and PEGylated nanoMOFs. This research highlights a facile PEGylation method with mPEG–PO3, providing new insights into the design of promising nanocarriers for drug delivery.
- Open Access
- 23 May 2020
- Published by Wiley in Cytometry Part A
- Vol. 97 (12) , 1222-1237
Image‐Based Cell Profiling Enables Quantitative Tissue Microscopy in Gastroenterology
Immunofluorescence microscopy is an essential tool for tissue‐based research, yet data reporting is almost always qualitative. Quantification of images, at the per‐cell level, enables “flow cytometry‐type” analyses with intact locational data but achieving this is complex. Gastrointestinal tissue, for example, is highly diverse: from mixed‐cell epithelial layers through to discrete lymphoid patches. Moreover, different species (e.g., rat, mouse, and humans) and tissue preparations (paraffin/frozen) are all commonly studied. Here, using field‐relevant examples, we develop open, user‐friendly methodology that can encompass these variables to provide quantitative tissue microscopy for the field. Antibody‐independent cell labeling approaches, compatible across preparation types and species, were optimized. Per‐cell data were extracted from routine confocal micrographs, with semantic machine learning employed to tackle densely packed lymphoid tissues. Data analysis was achieved by flow cytometry‐type analyses alongside visualization and statistical definition of cell locations, interactions and established microenvironments. First, quantification of Escherichia coli passage into human small bowel tissue, following Ussing chamber incubations exemplified objective quantification of rare events in the context of lumen‐tissue crosstalk. Second, in rat jejenum, precise histological context revealed distinct populations of intraepithelial lymphocytes between and directly below enterocytes enabling quantification in context of total epithelial cell numbers. Finally, mouse mononuclear phagocyte—T cell interactions, cell expression and significant spatial cell congregations were mapped to shed light on cell–cell communication in lymphoid Peyer's patch. Accessible, quantitative tissue microscopy provides a new window‐of‐insight to diverse questions in gastroenterology. It can also help combat some of the data reproducibility crisis associated with antibody technologies and over‐reliance on qualitative microscopy. © 2020 The Authors. Cytometry Part A published by Wiley Periodicals LLC. on behalf of International Society for Advancement of Cytometry.
- 23 May 2020
- Published by Wiley in Cytometry Part A
- Vol. 97 (12) , 1222-1237
Open AccessImage‐Based Cell Profiling Enables Quantitative Tissue Microscopy in Gastroenterology
Immunofluorescence microscopy is an essential tool for tissue‐based research, yet data reporting is almost always qualitative. Quantification of images, at the per‐cell level, enables “flow cytometry‐type” analyses with intact locational data but achieving this is complex. Gastrointestinal tissue, for example, is highly diverse: from mixed‐cell epithelial layers through to discrete lymphoid patches. Moreover, different species (e.g., rat, mouse, and humans) and tissue preparations (paraffin/frozen) are all commonly studied. Here, using field‐relevant examples, we develop open, user‐friendly methodology that can encompass these variables to provide quantitative tissue microscopy for the field. Antibody‐independent cell labeling approaches, compatible across preparation types and species, were optimized. Per‐cell data were extracted from routine confocal micrographs, with semantic machine learning employed to tackle densely packed lymphoid tissues. Data analysis was achieved by flow cytometry‐type analyses alongside visualization and statistical definition of cell locations, interactions and established microenvironments. First, quantification of Escherichia coli passage into human small bowel tissue, following Ussing chamber incubations exemplified objective quantification of rare events in the context of lumen‐tissue crosstalk. Second, in rat jejenum, precise histological context revealed distinct populations of intraepithelial lymphocytes between and directly below enterocytes enabling quantification in context of total epithelial cell numbers. Finally, mouse mononuclear phagocyte—T cell interactions, cell expression and significant spatial cell congregations were mapped to shed light on cell–cell communication in lymphoid Peyer's patch. Accessible, quantitative tissue microscopy provides a new window‐of‐insight to diverse questions in gastroenterology. It can also help combat some of the data reproducibility crisis associated with antibody technologies and over‐reliance on qualitative microscopy. © 2020 The Authors. Cytometry Part A published by Wiley Periodicals LLC. on behalf of International Society for Advancement of Cytometry.
- Open Access
A Murine Oral‐Exposure Model for Nano‐ and Micro‐Particulates: Demonstrating Human Relevance with Food‐Grade Titanium Dioxide
Human exposure to persistent, nonbiological nanoparticles and microparticles via the oral route is continuous and large scale (1012–1013 particles per day per adult in Europe). Whether this matters or not is unknown but confirmed health risks with airborne particle exposure warns against complacency. Murine models of oral exposure will help to identify risk but, to date, lack validation or relevance to humans. This work addresses that gap. It reports i) on a murine diet, modified with differing concentrations of the common dietary particle, food grade titanium dioxide (fgTiO2), an additive of polydisperse form that contains micro‐ and nano‐particles, ii) that these diets deliver particles to basal cells of intestinal lymphoid follicles, exactly as is reported as a “normal occurrence” in humans, iii) that confocal reflectance microscopy is the method of analytical choice to determine this, and iv) that food intake, weight gain, and Peyer's patch immune cell profiles, up to 18 weeks of feeding, do not differ between fgTiO2‐fed groups or controls. These findings afford a human‐relevant and validated oral dosing protocol for fgTiO2 risk assessment as well as provide a generalized platform for application to oral exposure studies with nano‐ and micro‐particles.
Open AccessA Murine Oral‐Exposure Model for Nano‐ and Micro‐Particulates: Demonstrating Human Relevance with Food‐Grade Titanium Dioxide
Human exposure to persistent, nonbiological nanoparticles and microparticles via the oral route is continuous and large scale (1012–1013 particles per day per adult in Europe). Whether this matters or not is unknown but confirmed health risks with airborne particle exposure warns against complacency. Murine models of oral exposure will help to identify risk but, to date, lack validation or relevance to humans. This work addresses that gap. It reports i) on a murine diet, modified with differing concentrations of the common dietary particle, food grade titanium dioxide (fgTiO2), an additive of polydisperse form that contains micro‐ and nano‐particles, ii) that these diets deliver particles to basal cells of intestinal lymphoid follicles, exactly as is reported as a “normal occurrence” in humans, iii) that confocal reflectance microscopy is the method of analytical choice to determine this, and iv) that food intake, weight gain, and Peyer's patch immune cell profiles, up to 18 weeks of feeding, do not differ between fgTiO2‐fed groups or controls. These findings afford a human‐relevant and validated oral dosing protocol for fgTiO2 risk assessment as well as provide a generalized platform for application to oral exposure studies with nano‐ and micro‐particles.